SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.88-1.2%Dec 22 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D.Lu who wrote (29205)8/19/1999 11:57:00 PM
From: Henry Niman  Read Replies (3) of 32384
 
Most readers of this board will also recognize guest speaker, Donald McDonnell, former LGND employee and inventor of key patent on the progesterone receptor
164.195.100.11
The patent is assigned to LGND and forms the bases for some of the more recent studies which will probably be discussed on the show.

McDonnell was also an inventor on an earlier patent done in collaboration with Bert O'Malley, another LGND consultant and another leader in the field of steroid hormone receptors.

Not sure how many NPR listeners will catch the connections, but readers of this board should know that most of the information being discussed tomorrow focuses on transcription control via intracellular recepters, a field led by Ligand's scientist and consultants.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext